Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria
Clinical trial NCT02410499 · WITHDRAWN
Trial details
- NCT number
- NCT02410499
- Sponsor
- Takeda
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-20
- Primary completion
- 2015-11-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.